Explore Products
Primary Cells

Human Heme-Oncology Peripheral Blood Mononuclear Cells

  • 180
Included Diagnoses: Lymphoma (including Non-Hodgkin and Hodgkin’s Lymphoma, B Cell Lymphoma, Burkitt’s Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma), Leukemias (including ALL, CML, CLL), Mulitple Myeloma and others.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC4327

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Heme-Oncology

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Heme-Oncology Peripheral Blood Mononuclear Cells are a type of mononuclear cell population derived from peripheral blood, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. Peripheral blood from patients with hematologic oncology conditions (e.g., leukemia, lymphoma, myeloma) .Round mononuclear cells; suspension growth; weak/no adhesion
.PBMCs play an important role in immune regulation: T/B cells mediate adaptive immunity (antigen recognition, antibody production), NK cells perform natural killing functions, and monocytes can differentiate into macrophages or dendritic cells, participating in antigen presentation and inflammation regulation. PBMCs themselves are non-tumorigenic, but may include malignant cells in the hematologic cancer context. PBMCs reflect immune dysregulation in hematologic cancers, influencing tumor immune escape, inflammation, and immune surveillance.

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Heme-Oncology Peripheral Blood Mononuclear Cells can be used to study the pathogenesis of hematological malignancies such as lymphoma and leukemia, evaluate drug efficacy, and develop new treatment strategies. For example, when evaluating new antibody drugs for hematological tumors, they can be used as effector cells to detect the antibody-dependent cellular cytotoxicity (ADCC) activity of antibodies

Inquiring Human Heme-Oncology Peripheral Blood Mononuclear Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button